 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > 2′-Deoxycytidine-5′-monophosphate for Sale > Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply buy - large image1

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply buy - image1

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply buy - image2

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply buy - image3

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply buy - image4

Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply

Name: Premium Quality 2 '-Deoxycytidine-5' -monophosphoric acid Powder for Pharmaceutical Intermediates Supply
Brand: ONERBIO
SKU: pr2606011675
Price: 11 USD
Availability: InStock

TDS

Unit Price: Get Latest Price 

CAS No.:

1032-65-1

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shanghai

Brand:

ONERBIO

Packaging:

25kg/drum

Price valid (until):

2026-07-01

Contact Supplier

 Chat Now

Wuhan Oner Biotech Co.,Ltd.

Company Type:

Distributor

Location:

China

Qualification:

Main Products:

Nutrition supplement material,Pharmaceutical raw material,Chemical raw material

 Visit Store

Product Description
Seller Information

Description

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 1

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 2

English name: 2 '-Deoxycytidine-5' -monophosphoric acid

CAS No:1032-65-1

Molecular formula: C9H14N3O7P

Molecular weight: 307.2

EINECS Accession number: 213-849-9

2 '-Deoxycytidine-5' -monophosphoric acid is a purine nucleoside analog with potent antiviral and, to a lesser extent, antineoplastic (anti-cancer) activity. As a raw material (Active Pharmaceutical Ingredient, API), it is a white to off-white, odorless crystalline powder. Chemically, it is designated as 9-β-D-arabinofuranosyladenine (Ara-A). Its molecular formula is C₁₀H₁₃N₅O₄, and it possesses a molecular weight of 267.24 g/mol. The CAS registry number for Vidarabine is 5536-17-4. The raw material is typically supplied with a purity of ≥98% (often ≥99% by HPLC for high-grade pharmaceutical use).

As a raw material, the physical characteristics of Vidarabine are critical for formulation (e.g., ophthalmic ointments, intravenous injections, or research solutions).

Appearance: Fine, crystalline powder.
Solubility: Vidarabine is slightly soluble in water (approx. 1.5–2.0 mg/mL at 25°C) and very slightly soluble in ethanol and chloroform. It is more soluble in dilute acids and alkalis. This low aqueous solubility is a key parameter formulators must address when developing liquid dosage forms.
Melting Point: The substance decomposes upon melting, typically in the range of 257–260°C.
Stability: In the solid state, Vidarabine is relatively stable when stored in a dry, light-resistant container. However, in aqueous solution, it is susceptible to deamination (enzymatic or chemical conversion) to hypoxanthine arabinoside (Ara-Hx), which has significantly reduced antiviral activity. Therefore, solutions must be freshly prepared or stabilized.

Vidarabine acts primarily as a DNA polymerase inhibitor. Once taken up by virally infected cells, Vidarabine is phosphorylated intracellularly to the active triphosphate (Vidarabine triphosphate, Ara-ATP). The mechanism involves two key steps:

Selective Inhibition: Ara-ATP preferentially inhibits viral DNA polymerase (specifically Herpesviridae) compared to host cellular DNA polymerases. This selective toxicity is the basis of its antiviral action.
Chain Termination: Ara-ATP is incorporated into the growing viral DNA chain. Because it lacks the required 3'-hydroxyl group (present in deoxyadenosine), it acts as a non-reversible chain terminator, halting viral replication.

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 3

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 4

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 5

ITEMS	STANDARDS		RESULTS
Description	White to almost white powder		White powder
UV absorbance ratio	A250/A260 A280/A260	0.41-0.49 2.03-2.71	0.45 2.14
PH	2.0-4.0		2.68
Loss on drying	≤5.0%		2.64%
Assay (UV)	≥98.0%		99.17%
Transmittance	≥98.5%		99.1%
Heavy metals	≤10ppm		＜10ppm
Purity (HPLC)	≥98.0%		99.6%
Conclusion	It complies to the standard

For regulatory compliance (e.g., USP, EP, JP), raw material Vidarabine must meet several rigorous standards:

Assay (by HPLC): 98.0% – 102.0% on an anhydrous basis.
Related Substances: Limits for specific impurities, notably Ara-Hx (NMT 2.0%), as well as any unspecified individual impurity (NMT 0.1%) and total impurities (NMT 2.0%).
Residual Solvents: Must comply with ICH Q3C guidelines (Class 1 and 2 solvents limited or absent).
Heavy Metals: NMT 20 ppm (typically lower for injectable grades).
Water Content (Karl Fischer): NMT 6.0% (the material is hygroscopic to a degree).
Microbial Limits: Total aerobic microbial count (TAMC) ≤ 1000 CFU/g, absence of S. aureus, P. aeruginosa, and Candida albicans.

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 6

As a raw material for finished pharmaceuticals, Vidarabine is historically recognized for its activity against:

DNA Viruses: Herpes simplex virus types 1 and 2 (HSV-1, HSV-2), Varicella-zoster virus (VZV), and Cytomegalovirus (CMV).
Clinical Use: Prior to the widespread use of Acyclovir, Vidarabine was a first-line therapy for severe Herpes simplex encephalitis and neonatal herpes. Today, its primary topical application is in the treatment of acute keratoconjunctivitis and recurrent epithelial keratitis caused by HSV. It is also used systemically (intravenous infusion) in some regions for immunocompromised patients with VZV infections.

Vidarabine is classified as a potential reproductive hazard and an irritant. Safety Data Sheets (SDS) mandate the following:

Hazard Statements (H360): May damage fertility or the unborn child (Category 1B).
Precautionary Measures: Use fume hoods and wear impermeable gloves (e.g., nitrile), lab coats, and safety goggles. Avoid generating airborne dust.
First Aid: In case of skin contact, wash immediately with copious soap and water. If inhaled, move to fresh air.
Storage: Store in tightly sealed, light-resistant containers at 2°C to 8°C (refrigerated) for long-term stability. Avoid freezing.

While superseded by newer nucleoside analogs (Acyclovir, Ganciclovir) for systemic use due to better bioavailability and lower toxicity, Vidarabine retains niche value. Its primary current application is ophthalmic ointment (3%) . Pharmacokinetically, the raw material has poor oral bioavailability (<10%) and is rapidly deaminated in the gastrointestinal tract, necessitating parenteral or topical administration.

Vidarabine API is a well-characterized, stable crystalline nucleoside analog. While its systemic use has declined, it remains a critical raw material for topical antiviral ophthalmic preparations, particularly where resistance to other agents occurs. Manufacturers must strictly control impurities (especially Ara-Hx) and water content to ensure final drug product efficacy.

Shop China Supply Nucleotides Cytosine Powder with Factory Price-Detailed Image 7

Certificates

Basic Info

Product Name:

2′-Deoxycytidine-5′-monophosphate

Other Name:

5′-Cytidylic acid,2′-deoxy-;Cytidine,2′-deoxy-,5′-(dihydrogen phosphate);Cytidine,2′-deoxy-,5′-phosphate;Cytidine,2′-deoxy-,phosphate;2′-Deoxy-5′-cytidylic acid;Deoxycytidine-5′-monophosphate;2′-Deoxycytidine 5′-phosphate;2′-Deoxycytidylic acid;dCMP;Deoxycytidine monophosphate;Deoxy-CMP;Deoxycytidine 5′-phosphate;2′-Deoxycytidine-5′-monophosphate;5′-Deoxycytidylic acid;148562-08-7;873077-04-4;1388718-78-2

CAS No.:

1032-65-1

Molecular Formula:

C9H14N3O7P

InChIKeys:

InChIKey=NCMVOABPESMRCP-SHYZEUOFSA-N

Molecular Weight:

307.2

Exact Mass:

307.20

EC Number:

213-849-9

UNII:

W7A9174XQL

HScode:

2934999090

Categories:

Bulk Drug Intermediates

Characteristics

PSA:

166.94000

XLogP3:

-2.17

Appearance:

White Crystalline Powder

Density:

2.0±0.1 g/cm3

Melting Point:

183-184 °C (decomp)

Boiling Point:

633.8±65.0 °C at 760 mmHg

Flash Point:

337.1±34.3 °C

Refractive Index:

1.743

Water Solubility:

soluble in water.H2O: 10 mg/mL, clear, colorless

Storage Conditions:

2-8°C

Collision Cross Section:

164 Å² [M+Na]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|165.59 Å² [M+H]+ [CCS Type: DT, Method: stepped-field]|166.62 Å² [M+Na]+ [CCS Type: DT, Method: stepped-field]|165.62 Å² [M-H]- [CCS Type: DT, Method: stepped-field]|161 Å² [M+Na]+ [CCS Type: TW, Method: calibrated with polyalanine]|157 Å² [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|164.7 Å² [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|162.4 Å² [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|163.7 Å² [M-H]-

See More 2′-Deoxycytidine-5′-monophosphate Properties 

Hazard Identification

Classification of the substance or mixture

Not classified.

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)	No symbol.
Signal word	No signal word
Hazard statement(s)	none
Prevention	none
Response	none
Storage	none
Disposal	none

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More 2′-Deoxycytidine-5′-monophosphate Safety Data Sheet 

Seller Information

Business Type:
Distributor

Main Products:
Nutrition supplement material,Pharmaceutical raw material,Chemical raw material

Location:
Changqing 5th Road, Jianghan District

Payment Terms:
TT against copy of documents

Average lead Time:
5

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
5-10

Year of Establishment:
2020

Wuhan Oner Biotech Co.,Ltd. located in the popular city of Wuhan, specilize in producing and developing pharmaceutical & its intermediates, Cosmetics Raw Material and Intermediate, food additive, Plant extracts,and in distributing the products of our own company. We serves our clients by supplying high-quality.These products are manufactured in ISO 9001 certified plants and have continuously been passing quality inspection by CIQ (China Entry & Exit Inspection and Quarantine Bureau),100% pass rate. Our company has professional staff who deal with chemical R&D and scientific management, and holds several sets of analyzing instruments with high efficiency and high sensitivity, such as HPLC, GC and Spectrophotometer. We have professional sales team, focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market , the products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc. With constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers.
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
China Most Professional Factory Supply High Qulity DCMP/2'-Deoxycytidine-5'-Monophosph CAS 1032-65-1	Pharmaceutical Grade/99	LEADER BIOCHEMICAL GROUP	Inquiry
2'-Deoxycytidine 5'-monophosphate	/	Creative Enzymes	Inquiry
2-Deoxycytidine-5-monophosphoric acid	/99.00	HANGZHOU LEAP CHEM CO., LTD.	Inquiry